Poland
Tuberculosis profile
Population  2013 38 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.65 (0.63–0.67) 1.7 (1.6–1.7)
Mortality (HIV+TB only) 0.012 (<0.01–0.018) 0.03 (0.02–0.05)
Prevalence  (includes HIV+TB) 10 (4.3–19) 27 (11–50)
Incidence  (includes HIV+TB) 8.3 (7.6–9) 22 (20–24)
Incidence (HIV+TB only) 0.096 (0.044–0.1) 0.25 (0.11–0.27)
Case detection, all forms (%) 85 (78–92)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.5 (0.3–0.77) 4.3 (2.7–6.5)
MDR-TB cases among notified pulmonary
TB cases
30 (18–47) 36 (22–54)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 4 132   408
Pulmonary, clinically diagnosed 1 875   214
Extrapulmonary 396   18
       
Total new and relapse 7 043    
Previously treated, excluding relapses 207    
Total cases notified 7 250    
Among 7 043 new and relapse cases:
116 (2%) cases aged under 15 years; male:female ratio: 2.2
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 3 835 (93%) 489 (58%) 4 324
Laboratory-confirmed RR-/MDR-TB cases     47
Patients started on MDR-TB treatment      
TB/HIV 2013 Number (%)
TB patients with known HIV status 35 (<1)
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 60
Previously treated cases, excluding relapse, registered in 2012 45
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 35
XDR-TB cases started on second-line treatment in 2011 0
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-04-25 Data: www.who.int/tb/data